ONLINE DATABASE SEARCH - HIV-LS-343-MEMO
1. 48543 HIV-LS-343; PUBMED-HIV-3/6/2006
Microwave-Accelerated Synthesis of P1'-Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimicking Scaffold
Ekegren, JK, Ginman, N, Johansson, A, Wallberg, H, Larhed, M, Samuelsson, B, Unge, T, and Hallberg, A
J Med Chem 2006. 49(5): 1828-1832
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16509598&dopt=abstract
2. 48544 HIV-LS-343; PUBMED-HIV-3/6/2006
Synthesis and Anti-HIV Activity of d- and l-Thietanose Nucleosides
Choo, H, Chen, X, Yadav, V, Wang, J, Schinazi, RF, and Chu, CK
J Med Chem 2006. 49(5): 1635-47
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16509580&dopt=abstract
3. 48545 HIV-LS-343; PUBMED-HIV-3/6/2006
Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
Sato, M, Motomura, T, Aramaki, H, Matsuda, T, Yamashita, M, Ito, Y, Kawakami, H, Matsuzaki, Y, Watanabe, W, Yamataka, K, Ikeda, S, Kodama, E, Matsuoka, M, and Shinkai, H
J Med Chem 2006. 49(5): 1506-8
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16509568&dopt=abstract
4. 48546 HIV-LS-343; PUBMED-HIV-3/6/2006
Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors
Randolph, JT, Huang, PP, Flosi, WJ, Degoey, D, Klein, LL, Yeung, CM, Flentge, C, Sun, M, Zhao, C, Dekhtyar, T, Mo, H, Colletti, L, Kati, W, Marsh, KC, Molla, A, and Kempf, DJ
Bioorg Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16504523&dopt=abstract
5. 48547 HIV-LS-343; PUBMED-HIV-3/6/2006
Tetrazole thioacetanilides: Potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant
Muraglia, E, Kinzel, OD, Laufer, R, Miller, MD, Moyer, G, Munshi, V, Orvieto, F, Palumbi, MC, Pescatore, G, Rowley, M, Williams, PD, and Summa, V
Bioorg Med Chem Lett 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16503141&dopt=abstract
6. 48548 HIV-LS-343; PUBMED-HIV-3/6/2006
Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site
Eberhardy, SR, Goncalves, J, Coelho, S, Segal, DJ, Berkhout, B, and Barbas, CF 3rd
J Virol 2006. 80(6): 2873-83
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16501096&dopt=abstract
7. 48549 HIV-LS-343; PUBMED-HIV-3/6/2006
Cyclophilin A and TRIM5{alpha} Independently Regulate Human Immunodeficiency Virus Type 1 Infectivity in Human Cells
Sokolskaja, E, Berthoux, L, and Luban, J
J Virol 2006. 80(6): 2855-62
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16501094&dopt=abstract
8. 48550 HIV-LS-343; SCIFINDER-HIV-2/27/2006
C-Glycoside analogues of b-galactosylceramide with a simple ceramide substitute: Synthesis and binding to HIV-1 gp120
Augustin, Line A, Fantini, Jacques, and Mootoo, David R
Bioorganic & Medicinal Chemistry 2006. 14(4): 1182-1188
9. 48551 HIV-LS-343; PUBMED-HIV-3/6/2006
Interaction of small molecule inhibitors of HIV-1 entry with CCR5
Seibert, C, Ying, W, Gavrilov, S, Tsamis, F, Kuhmann, SE, Palani, A, Tagat, JR, Clader, JW, McCombie, SW, Baroudy, BM, Smith, SO, Dragic, T, Moore, JP, and Sakmar, TP
Virology 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16494916&dopt=abstract
10. 48552 HIV-LS-343; SCIFINDER-HIV-2/27/2006
QSAR studies on the use of 5,6-dihydro-2-pyrones as HIV-1 protease inhibitors
Agrawal, Vijay K, Singh, Jyoti, Mishra, Krishna C, Khadikar, Padmakar V, and Jaliwala, Yusuf Ali
ARKIVOC (Gainesville, FL, United States) 2006.(2): 162-177
11. 48553 HIV-LS-343; SCIFINDER-HIV-2/27/2006
Preparation of amino acid-containing nucleotides as prodrugs and antiviral agents
Boojamra, Constantine G, Lin, Kuei-Ying, Mackman, Richard L, Markevitch, David Y, Petrakovsky, Oleg V, Ray, Adrian S, and Zhang, Lijun
PATENT: WO 2006015261 ISSUE DATE: 20060209
APPLICATION: 2005 PP: 173 pp.
ASSIGNEE: (Gilead Sciences, Inc. USA
12. 48554 HIV-LS-343; PUBMED-HIV-3/6/2006
Inhibition of human immunodeficiency virus type 1 infection in macrophages by an alpha-v integrin blocking antibody
Bosch, B, Clotet-Codina, I, Blanco, J, Pauls, E, Coma, G, Cedeno, S, Mitjans, F, Llano, A, Bofill, M, Clotet, B, Piulats, J, and Este, JA
Antiviral Res 2006. 69(3): 173-80
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16473416&dopt=abstract
13. 48555 HIV-LS-343; SCIFINDER-HIV-2/27/2006
Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity
Peng, Gang, Lei, Ke Jian, Jin, Wenwen, Greenwell-Wild, Teresa, and Wahl, Sharon M
Journal of Experimental Medicine 2006. 203(1): 41-46
14. 48556 HIV-LS-343; PUBMED-HIV-3/6/2006
Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy
Rodes, B, Sheldon, J, Toro, C, Jimenez, V, Alvarez, MA, and Soriano, V
J Antimicrob Chemother 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16464891&dopt=abstract
15. 48557 HIV-LS-343; PUBMED-HIV-3/6/2006
Mining the NCI antiviral compounds for HIV-1 integrase inhibitors
Deng, J, Kelley, JA, Barchi, JJ, Sanchez, T, Dayam, R, Pommier, Y, and Neamati, N
Bioorg Med Chem 2006.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16460953&dopt=abstract
16. 48558 HIV-LS-343; SCIFINDER-HIV-2/27/2006
Herbal extract with antiviral properties
Abdullahi, Jacob J
PATENT: US 2006024386 ISSUE DATE: 20060202
APPLICATION: 2005-58730
ASSIGNEE: (Nigeria)
17. 48559 HIV-LS-343; WOS-HIV-2/26/2006
Identification of sanguinarine as a novel HIV protease inhibitor from high-throughput screening of 2,000 drugs and natural products with a cell-based assay
Cheng, TJ, Goodsell, DS, and Kan, CC
LETTERS IN DRUG DESIGN & DISCOVERY 2005. 2(5): 364-371, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235167800003
18. 48560 HIV-LS-343; WOS-HIV-2/26/2006
Structure based design of inhibitors of aspartic protease of HIV-1
Frecer, V, Jedinak, A, Tossi, A, Berti, F, Benedetti, F, Romeo, D, and Miertus, S
LETTERS IN DRUG DESIGN & DISCOVERY 2005. 2(8): 638-646, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235168100010
19. 48561 HIV-LS-343; WOS-HIV-2/26/2006
p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome
Darbinian-Sarkissian, N, Darbinyan, A, Otte, J, Radhakrishnan, S, Sawaya, BE, Arzumanyan, A, Chipitsyna, G, Popov, Y, Rappaport, J, Amini, S, and Khalili, K
GENE THERAPY 2006. 13(4): 288-295, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235184000002
20. 48562 HIV-LS-343; WOS-HIV-3/5/2006
How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors
Hamza, A and Zhan, CG
JOURNAL OF PHYSICAL CHEMISTRY B 2006. 110(6): 2910-2917, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235373400063
21. 48563 HIV-LS-343; WOS-HIV-3/5/2006
Synthesis and antiviral evaluation of carbocyclic 3 '-azidothymidine (AZT) analogues and their cycloSal-phosphate triesters
Ludek, OR, Balzarini, J, and Meier, C
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY 2006.(4): 932-940, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235404000013
22. 48564 HIV-LS-343; WOS-HIV-3/5/2006
Anti-HIV I/II activity and molecular cloning of a novel mannose/sialic acid-binding lectin from rhizome of Polygonatum cyrtonema Hua
An, J, Liu, JZ, Wu, CF, Li, J, Dai, L, Van Damme, E, Balzarini, J, De Clercq, E, Chen, F, and Bao, JK
ACTA BIOCHIMICA ET BIOPHYSICA SINICA 2006. 38(2): 70-78, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000235370000001